NCT00482235
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
Not specified
Clinical trial condition
Pulmonary Disease, Chronic Obstructive
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
787 public trials
11 recruiting studies
Pulmonary Disease, Chronic Obstructive trial results
NCT01964352
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1237.25.10504 Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
- 1237.25.10507 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
- 1237.25.10517 Boehringer Ingelheim Investigational Site Panama City, Florida, United States
- 1237.25.10505 Boehringer Ingelheim Investigational Site Coeur d'Alene, Idaho, United States
NCT01794390
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- UK GP sites Cambridge, United Kingdom
Completed
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.
NCT01533935
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1237.14.01404 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
- 1237.14.01414 Boehringer Ingelheim Investigational Site Austell, Georgia, United States
- 1237.14.01417 Boehringer Ingelheim Investigational Site Baltimore, Maryland, United States
- 1237.14.01418 Boehringer Ingelheim Investigational Site Rochester, Minnesota, United States
Completed
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients
NCT01533922
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1237.13.01302 Boehringer Ingelheim Investigational Site Torrance, California, United States
- 1237.13.01308 Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
- 1237.13.01304 Boehringer Ingelheim Investigational Site Livonia, Michigan, United States
- 1237.13.01307 Boehringer Ingelheim Investigational Site Pittsburgh, Pennsylvania, United States
NCT00720499
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1237.9.00152 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
- 1237.9.00155 Boehringer Ingelheim Investigational Site Tampa, Florida, United States
- 1237.9.00151 Boehringer Ingelheim Investigational Site Philadelphia, Pennsylvania, United States
- 1237.9.00154 Boehringer Ingelheim Investigational Site Killeen, Texas, United States
NCT00696020
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1237.4.0118 Boehringer Ingelheim Investigational Site Riverside, California, United States
- 1237.4.0103 Boehringer Ingelheim Investigational Site San Diego, California, United States
- 1237.4.0115 Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
- 1237.4.0105 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
NCT02515799
- Conditions
- Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +10 more
- Locations
-
- Medaimun GmbH Frankfurt/M, Hesse, Germany
NCT01067248
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Chronic Disease, +11 more
- Locations
-
Not specified
NCT01431287
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1237.6.01106 Boehringer Ingelheim Investigational Site Greer, California, United States
- 1237.6.01120 Boehringer Ingelheim Investigational Site Fort Collins, Colorado, United States
- 1237.6.01131 Boehringer Ingelheim Investigational Site Danbury, Connecticut, United States
- 1237.6.01117 Boehringer Ingelheim Investigational Site Waterbury, Connecticut, United States